Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium

This study has been completed.

Study NCT00072150 Information provided by Cancer and Leukemia Group B

First Received: November 4, 2003 Last Updated: April 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	March 2006 (Final data collection date for primary outcome measure)

Publications:

Rosenberg JE, Halabi S, Sanford BL, Himelstein AL, Atkins JN, Hohl RJ, Millard F, Bajorin DF, Small EJ; for the Cancer and Leukemia Group B. Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. Ann Oncol. 2008 Feb 13; [Epub ahead of print]

Back to top of Main Content